raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:555402

NAD(P)HX dehydratase deficiency

Synonyms: CARKD deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

A rare neurometabolic disease characterized by infantile onset of repeated episodes of developmental regression and neurodegeneration, often triggered by febrile illnesses. Patients present with lethargy, hypotonia, irritability, gait ataxia, loss of speech, movement disorder, seizures, ophthalmoplegia, and hearing loss. Brain imaging shows generalized cerebral atrophy and bilateral basal ganglia abnormalities. Extensive skin lesions, cardiomyopathy, and pancytopenia have been reported in association. The condition is fatal in the first years of life.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enNAD(P)HX dehydratase deficiencyCARKD deficiency
frDéficit en NAD(P)HX déshydrataseDéficit en CARKD
deNAD(P)HX-Dehydratase-MangelCARKD-Mangel
esDeficiencia de NAD(P)HX deshidratasaDeficiencia de CARKD
itDeficit di NAD(P)HX deidratasi
nlNAD(P)HX-dehydratasedeficiëntieCARKD-deficiëntie
ptDeficiência de NAD(P)HX desidratase
plNiedobór dehydratazy NAD(P)HX= en
csDeficit NAD(P)HX dehydratázyDeficit CARKD
ukДефіцит дегідратази NAD(P)HXДефіцит серцево-судинної системи
zhNAD(P)HX脱水酶缺乏CARKD基因缺陷
trNAD (P) HX dehidrataz eksikliğiCARKD eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM618321Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C5YNTBTattributedvalidated
MONDO0034121Evalidated
UMLSC5193026Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NAXDDisease-causing germline mutation(s) inAssessedHGNC:25576ENSG0000021399561591013q34NAD(P)HX dehydratase30576410[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families6 casesWorldwideCase(s)Validated30576410[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_30576410[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

30 annotations · validated 2026-01-12
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002376Developmental regression
Frequent (79-30%)
HP:0008066Abnormal blistering of the skin
HP:0001903Anemia
HP:0002059Cerebral atrophy
HP:0008972Decreased activity of mitochondrial respiratory chain
HP:0002353EEG abnormality
HP:0011227Elevated circulating C-reactive protein concentration
HP:0003236Elevated circulating creatine kinase concentration
HP:0001288Gait disturbance
HP:0002490Increased CSF lactate
HP:0002151Increased circulating lactate concentration
HP:0011355Localized skin lesion
HP:0003198Myopathy
HP:0001250Seizure
HP:0002013Vomiting
Occasional (29-5%)
HP:0002134Abnormal basal ganglia morphology
HP:0001251Ataxia
HP:0001638Cardiomyopathy
HP:0000518Cataract
HP:0030915Cerebellar edema
HP:0000405Conductive hearing impairment
HP:0001635Congestive heart failure
HP:0001332Dystonia
HP:0031956Elevated circulating aspartate aminotransferase concentration
HP:0001254Lethargy
HP:0012819Myocarditis
HP:0000602Ophthalmoplegia
HP:0001876Pancytopenia
HP:0033725Thin corpus callosum
Very rare (<4-1%)
HP:0002209Sparse scalp hair

Run the differential on the 1 obligate / very frequent terms

Annotation source: 39822994[PMID]_36158054[PMID]_34161859[PMID]

7

Sources for this card